Saudi Arabia to host 8th Global Health Exhibition in Riyadh
Held under the theme 'Invest in Health,' the event aims to advance the Kingdom's Vision 2030 goals by accelerating the transformation of its healthcare sector and reinforcing Saudi Arabia's position as a global hub for health innovation and investment.
The exhibition will serve as a major platform for forging partnerships, exploring investment prospects, and showcasing cutting-edge technologies in healthcare, including advances in telemedicine and initiatives promoting healthier lifestyles.
Building on the success of last year's edition—which generated over SAR50 billion ($13.3 billion) in deals and drew more than 100,000 visitors from 80 countries—the upcoming event is expected to continue driving momentum in Saudi Arabia's health sector.
The exhibition underscores the Kingdom's expanding role on the global health stage, bolstered by initiatives like the National Biotechnology Strategy and its hosting of major international gatherings, such as the Fourth Global High-Level Ministerial Conference on Antimicrobial Resistance and the CPHI Middle East pharmaceutical expo.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
7 hours ago
- Khaleej Times
PureHealth reports Dh13.6 billion in revenue and Dh1.03 billion in net profit for H1
PureHealth Holding, the largest healthcare group in the Middle East, on Thursday announced a 9 per cent year-on-year revenue increase to Dh13.6 billion in H1 2025, driven by broad-based growth across both its healthcare and insurance verticals. Ebitda rose 8 per cent year-on-year to Dh2.3 billion in H1-2025, while net profit reached Dh1.03 billion, up 2 per cent year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' The Care vertical was the largest contributor to revenue during the period, accounting for 72 per cent of the group's top-line at dh9.8 Billion in revenue, up 7 per cent year-on-year in h1 2025. This growth witnessed across several segments, including hospitals, diagnostics, and technology. Performance in UAE and UK was driven by a 13 per cent increase in outpatient volumes to 4.4 million visits, and a 7 per cent rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5 per cent year-on-year to Dh2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19 per cent year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170 per cent year-on-year to Dh367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14 per cent year-on-year to Dh3.8 billion, supported by an 8 per cent rise in Gross Written Premiums (GWP) to Dh4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6 per cent year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to Ebitda ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid Dh1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt.
Khaleej Times
7 hours ago
- Khaleej Times
Response Plus Holding reports Dh248 million revenue in H1
Response Plus Holding PJSC, the largest pre-hospital care and emergency medical services provider in the UAE and KSA, has achieved revenue of Dh248.06 million in the first six months of 2025, a growth of 18% compared to Dh209.88 million recorded in the same period last year. Announcing the company's interim financial results for the first half of 2025, RPM registered net profit of Dh20.32 million, while total assets touched Dh404.32 million, up from Dh387.44 million as of December 31, 2024, reflecting continued balance sheet strength and sustained investment momentum. The Earnings Per Share (EPS) for the period was Dh0.10. As part of its commitment to deliver shareholder value, the Board of Directors has approved an interim cash dividend distribution of Dh18 million to the shareholders. Dr Rohil Raghavan, Chief Executive Officer of Response Plus Holding, said: 'The first half of 2025 reflects our strategic agility and continued investment in excellence. From expanding into new geographies to launching the first-of-its-kind services in the region, we are driving impactful growth while prioritizing operational efficiencies. With a strong foundation and forward-looking initiatives, we are well-positioned to deliver greater value to our clients, partners, and shareholders.' RPM delivered strategic milestones during the first half of 2025, reinforcing its leadership in regional and global emergency medical care. The company expanded its aviation emergency operations to The Bahamas, demonstrating its capabilities to scale internationally while enhancing its disaster and air evacuation readiness. During the Hajj season, the company deployed 350 medical professionals and 125 ambulances in 18 clinics across nine stations of Saudi Arabia Railways to support millions of pilgrims visiting the Holy sites. RPM also signed a MoU with Falcon Aviation to operate the UAE's first air ambulance service, a landmark step in enhancing the country's emergency response infrastructure. RPM currently operates over 420 medical sites through key subsidiaries including Prometheus Medical, Occumed Clinic, Health Tech Training Centre, and Medical Manpower Supply. With operations spanning the UAE, KSA, Oman, India, the UK, Switzerland, and Norway, RPM remains firmly committed to redefining the future of pre-hospital emergency medical services.
Zawya
10 hours ago
- Zawya
Nigeria takes bold steps toward Hepatitis-free future with World Health Organization (WHO)'s support
The World Health Organization (WHO) has collaborated with the Government of Nigeria and hepatitis stakeholders to raise awareness and promote early diagnosis and treatment for World Hepatitis Day 2025. The global event, observed annually on 28 July, raises awareness about viral hepatitis- an inflammation of the liver that can lead to chronic liver disease and liver cancer. Hepatitis includes five types: A, B, C, D, and E. In the WHO African Region, over 70 million people suffer from chronic hepatitis B or C, but fewer than 10% are diagnosed or treated. Nigeria, with 325,000 new infections in 2022, ranks third globally in hepatitis prevalence. Chronic hepatitis B and C can lead to liver damage and cancer, even though they are preventable, treatable, and, in the case of hepatitis C, curable. This year's theme, 'Hepatitis: Let's Break It Down,' calls for action to remove financial, social, and systemic barriers, including stigma, that prevent hepatitis elimination and liver cancer prevention. For 2025 World Hepatitis Day, WHO joined the Ministry of Health and Social Welfare and its partners to mark the occasion with a ministerial press briefing at the Federal Secretariat, and launched a three-day hepatitis B screening, on the stop vaccinations for those who test negative, and linkage to treatment programme for those who test positive at the National Assembly Complex in Abuja. The event at the National Assembly in Abuja brought together health officials, legislators, and the public to address the issue of hepatitis. Addressing journalists at the press briefing, the Minister of Health and Social Welfare, Professor Mohammed Pate, represented by Dr Godwin Ntadom, Director Public Health Department, FMOH, reiterated Nigeria's commitment to combating hepatitis. He noted that the burden and cost of hepatitis treatment in the country is still very high and, as such, has a huge economic impact on the country and called for collective action in eliminating the disease. Dr Ntadom said, 'hepatitis costs Nigeria between ₦13.3 trillion and ₦17.9 trillion annually in direct and indirect costs. He also announced, 'Project 365,' a nationwide campaign aimed at eliminating Hepatitis C and halting Hepatitis B transmission by 2030. 'The project will support the ongoing efforts to eliminate mother-to-child transmission of HIV, hepatitis, and STIs, alongside expanding local pharmaceutical manufacturing through funding, the establishment of the Viral Elimination Fund, tax incentives, regulatory reforms, and legislative support. Nigeria must no longer hold the third-highest hepatitis burden globally. We have the science, we have the strategy, and we will act together, boldly and urgently, toward a hepatitis-free Nigeria, he said. WHO's Acting Representative in Nigeria, Dr Alex Gasasira, represented by Dr Mya Ngon, cluster lead for Universal Health Coverage (UHC) Communicable and Noncommunicable Diseases (NCDs) praised Nigeria's triple elimination initiative for HIV, hepatitis, and STIs, and emphasized the importance of reducing treatment costs, boosting local production, and expanding screening to achieve healthcare equity. WHO urges Nigeria and other nations to: • Ensure hepatitis B vaccination within 24 hours of birth; • Integrate hepatitis testing and treatment into primary healthcare services; • Address stigma and misinformation; • Secure sustainable domestic funding for hepatitis programs; and • Protect the rights of individuals living with hepatitis, especially in healthcare and employment. She reiterated WHO's commitment to supporting Nigeria's efforts to strengthen its health systems and expand access to affordable diagnostics, vaccines, and treatments. A beneficiary of the screening, Fash Yommie, 53, from Abuja, shared that he took the test to know his status. 'I took the test to know my status, and I am relieved to have tested negative. I now understand the importance of hepatitis prevention. I will start taking precautionary measures, such as avoiding sharing needles and ensuring proper hygiene with food and water, to protect myself and my loved ones from infection. I encourage everyone to get tested and vaccinated, as early detection is key to preventing this disease. "Early detection and vaccination are crucial in preventing the spread of hepatitis. Hepatitis B is transmitted through contact with infected blood or fluids, hepatitis C via blood-to-blood contact like sharing needles, and hepatitis A and E through contaminated food or water. Nigeria has enhanced hepatitis B prevention by adding the vaccine to the national schedule, supported by WHO, Gavi, UNICEF, and partners, to vaccinate all newborns and children and reduce early transmission. This year's activities reflect the broader goal of integrating hepatitis services into Nigeria's primary healthcare system, making screening and treatment more accessible to vulnerable populations. The National Assembly event is part of WHO's ongoing collaboration with Nigeria to achieve universal health coverage and align with the 2030 Global Health Agenda. Through national and local partnerships, WHO supports Nigeria in reducing the hepatitis burden and improving public health outcomes. The three-day screening serves as a reminder that hepatitis is preventable, and everyone has a role in raising awareness and preventing its spread. Distributed by APO Group on behalf of World Health Organization (WHO) - Nigeria.
